1. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial. (January 2023) Authors: Koehm, Michaela; Rossmanith, Tanja; Foldenauer, Ann C; Herrmann, Eva; Brandt-Jürgens, Jan; Burmester, Gerd R; Kellner, Herbert; Kiltz, Uta; Kofler, David M; Rech, Jürgen; Mojtahed-Poor, Sorwe; Jonetzko, Christin; Burkhardt, Harald; Behrens, Frank; Alten, Rieke H.E.; Benesova, Karolina; Bergner, R... Journal: Lancet Issue: Volume 5:Number 1(2023) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0163 LOW CARDIOVASCULAR EVENT RATE DURING TOCILIZUMAB TREATMENT IN THE NON-INTERVENTIONAL STUDY ICHIBAN. (June 2019) Authors: Specker, Christof; Alberding, Annette; Aringer, Martin; Burmester, Gerd Rüdiger; Hofmann, Michael W.; Kästner, Peter; Kellner, Herbert; Luig, Christina; Moosig, Frank; Sieburg, Maren; Tony, Hans-Peter; Fliedner, Gerhard Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗